CY1125080T1 - Συστοιχια αντιγονου - Google Patents

Συστοιχια αντιγονου

Info

Publication number
CY1125080T1
CY1125080T1 CY20211100322T CY211100322T CY1125080T1 CY 1125080 T1 CY1125080 T1 CY 1125080T1 CY 20211100322 T CY20211100322 T CY 20211100322T CY 211100322 T CY211100322 T CY 211100322T CY 1125080 T1 CY1125080 T1 CY 1125080T1
Authority
CY
Cyprus
Prior art keywords
antigen
antigone
components
array
relates
Prior art date
Application number
CY20211100322T
Other languages
English (en)
Inventor
Christian Harwanegg
Georg MITTERER
Original Assignee
Macroarray Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macroarray Diagnostics Gmbh filed Critical Macroarray Diagnostics Gmbh
Publication of CY1125080T1 publication Critical patent/CY1125080T1/el

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346Nanoparticles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η παρούσα εφεύρεση αφορά συστοιχίες αντιγόνων (antigen arrays) και μεθόδους για την ανίχνευση ανοσοσφαιρινών ειδικών για οιοδήποτε από τα αντιγόνα της συστοιχίας σε κάποιο βιολογικό δείγμα. Ειδικότερα, η παρούσα εφεύρεση αφορά συστοιχίες αντιγόνων που περιλαμβάνουν ομάδες σφαιριδίων επικαλυμμένων με αντιγόνο, καθηλωμένα σε κάποια στερεά βάση στήριξης. Επιπλέον, στο παρόν περικλείονται φύσιγγες, σύνολα (κιτ) και κάποια διάταξη αποτελούμενη από τη συστοιχία αντιγόνων και μεθόδους που χρησιμοποιούν αυτά.
CY20211100322T 2016-03-30 2021-04-13 Συστοιχια αντιγονου CY1125080T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16162859 2016-03-30
PCT/EP2017/057481 WO2017167843A1 (en) 2016-03-30 2017-03-30 Antigen array

Publications (1)

Publication Number Publication Date
CY1125080T1 true CY1125080T1 (el) 2023-03-24

Family

ID=55913441

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100322T CY1125080T1 (el) 2016-03-30 2021-04-13 Συστοιχια αντιγονου

Country Status (20)

Country Link
US (1) US11740232B2 (el)
EP (1) EP3436823B1 (el)
JP (1) JP7027330B2 (el)
KR (1) KR102392752B1 (el)
CN (1) CN109196361B (el)
BR (1) BR112018069783A2 (el)
CA (1) CA3016250C (el)
CY (1) CY1125080T1 (el)
DK (1) DK3436823T3 (el)
EA (1) EA039044B1 (el)
ES (1) ES2862533T3 (el)
HR (1) HRP20210660T1 (el)
HU (1) HUE054231T2 (el)
LT (1) LT3436823T (el)
PL (1) PL3436823T3 (el)
PT (1) PT3436823T (el)
RS (1) RS61807B1 (el)
SA (1) SA518400078B1 (el)
SI (1) SI3436823T1 (el)
WO (1) WO2017167843A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11480568B2 (en) * 2017-09-28 2022-10-25 Yeda Research And Development Co. Ltd. Diagnosis of autoimmune diseases
KR102177672B1 (ko) * 2019-02-01 2020-11-12 주식회사 압타머사이언스 압타머를 이용한 다중(multiplex) PCR 방법
JP7070963B2 (ja) * 2019-02-26 2022-05-18 アール・ナノバイオ株式会社 タンパク質又は抗体チップ用のカセット、及び該カセットを用いる検査装置
CN110412270A (zh) * 2019-06-26 2019-11-05 四川大学华西医院 Ssna1自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
WO2021086721A1 (en) * 2019-10-31 2021-05-06 Siemens Healthcare Diagnostics Inc. Methods and apparatus for hashing and retrieval of training images used in hiln determinations of specimens in automated diagnostic analysis systems
WO2021187398A1 (ja) * 2020-03-16 2021-09-23 東レ株式会社 体液検体中のスギアレルゲン特異的IgE抗体の検出方法および検出用キット
CN113125739B (zh) * 2021-04-16 2022-07-26 杭州浙大迪迅生物基因工程有限公司 一种荧光芯片定量检测试剂盒
JPWO2023027184A1 (el) * 2021-08-27 2023-03-02
CN114167050A (zh) * 2021-12-09 2022-03-11 牟奕 C型青霉素类与头孢菌素类抗生素抗体检测的固相矩阵及其制备方法
WO2024062057A1 (en) * 2022-09-23 2024-03-28 Diesse Diagnostica Senese S.P.A. Apparatus for performing immunometric tests
EP4343335A1 (en) * 2022-09-23 2024-03-27 Diesse Diagnostica Senese S.p.a. Apparatus for performing immunometric tests
CN115598337A (zh) * 2022-10-24 2023-01-13 江苏三联生物工程股份有限公司(Cn) 检测屋尘螨过敏原组分的芯片、试剂盒及其制备方法
US11802870B1 (en) * 2022-12-13 2023-10-31 Panazee Kinetic immunoassay systems and methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945293A (en) * 1997-10-09 1999-08-31 Coulter International Corp. Protein-colloidal metal-aminodextran coated particle and methods of preparation and use
AU2464299A (en) 1998-01-22 1999-08-09 Luminex Corporation Microparticles with multiple fluorescent signals
US7101510B2 (en) * 1999-02-16 2006-09-05 Applera Corporation Matrix storage and dispensing system
EP1195606A1 (en) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay
CN1430052A (zh) * 2001-12-31 2003-07-16 合富生化科技股份有限公司 过敏原检测芯片
WO2004104586A1 (en) * 2003-05-16 2004-12-02 Ciphergen Biosystems, Inc. Allergen test devices and methods for their use
JP2005077284A (ja) 2003-09-01 2005-03-24 Seiko Epson Corp 粒子アレイの製造装置及び製造方法と標的物質の検出方法
JP2005114576A (ja) * 2003-10-08 2005-04-28 Hitachi Software Eng Co Ltd 両親媒性分子固定化ビーズ、その製造方法、及びキャピラリビーズアレイのビーズ配列方法
CN1844928A (zh) * 2006-03-21 2006-10-11 深圳大学 一种检测食物过敏原的仪器
US20080176253A1 (en) 2006-05-10 2008-07-24 The Board Of Regents Of The University Of Texas System Detecting human or animal immunoglobin-e
CN101661034A (zh) * 2008-08-28 2010-03-03 上海领潮生物科技有限公司 同时进行多种生物标志物并行检测的方法和芯片试纸
US9523701B2 (en) * 2009-07-29 2016-12-20 Dynex Technologies, Inc. Sample plate systems and methods
GB201002601D0 (en) * 2010-02-16 2010-03-31 Microtest Matrices Ltd Allergen microarray
ES2576927T3 (es) * 2010-10-22 2016-07-12 T2 Biosystems, Inc. Sistemas de RMN y métodos para la detección rápida de analitos
US8409807B2 (en) * 2010-10-22 2013-04-02 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
US20150293120A1 (en) * 2012-03-27 2015-10-15 Protagen Ag Marker sequences for rheumatoid arthritis
US10921313B2 (en) * 2012-07-16 2021-02-16 Micobiomed., Ltd Point of care testing assay system using novel microfluidics
US20160060687A1 (en) * 2014-07-18 2016-03-03 Cdi Laboratories, Inc. Methods and compositions to identify, quantify, and characterize target analytes and binding moieties

Also Published As

Publication number Publication date
LT3436823T (lt) 2021-06-10
RS61807B1 (sr) 2021-06-30
US11740232B2 (en) 2023-08-29
US20190079083A1 (en) 2019-03-14
KR102392752B1 (ko) 2022-04-29
HUE054231T2 (hu) 2021-08-30
CA3016250A1 (en) 2017-10-05
PL3436823T3 (pl) 2021-08-09
KR20180123681A (ko) 2018-11-19
EA201892164A1 (ru) 2019-03-29
BR112018069783A2 (pt) 2019-01-29
SA518400078B1 (ar) 2022-08-14
CN109196361A (zh) 2019-01-11
ES2862533T3 (es) 2021-10-07
WO2017167843A1 (en) 2017-10-05
PT3436823T (pt) 2021-04-22
JP7027330B2 (ja) 2022-03-01
SI3436823T1 (sl) 2021-08-31
JP2019515254A (ja) 2019-06-06
EP3436823B1 (en) 2021-02-24
CA3016250C (en) 2023-12-05
DK3436823T3 (da) 2021-04-26
EP3436823A1 (en) 2019-02-06
HRP20210660T1 (hr) 2021-05-28
EA039044B1 (ru) 2021-11-25
CN109196361B (zh) 2021-12-07

Similar Documents

Publication Publication Date Title
CY1125080T1 (el) Συστοιχια αντιγονου
CY1124717T1 (el) Μεθοδοι, kit και συσκευη για επεκταση πληθυσμου κυτταρων
CO2018010855A2 (es) Nuevos anticuerpos anti-sirpa y sus aplicaciones terapéuticas
CY1123868T1 (el) Συνδυαστικη ανοσοθεραπεια ογκου
CY1124944T1 (el) Βελτιστοποιημενα αμφιειδικα αντισωματα αντι-cd3 και χρησεις αυτων
CY1124714T1 (el) Συζευγματα πυρρολοβενζοδιαζεπινης-αντισωματος
CY1124691T1 (el) Διειδικα αντισωματα ειδικα για pd1 και τιμ3
BR112017009728A2 (pt) anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, método para produzir o anticorpo, composição, usos de um anticorpo e métodos de tratamento de um distúrbio
CY1123259T1 (el) Αντισωματα anti-pvrig και μεθοδοι χρησης
CL2018000431A1 (es) Anticuerpos anti-bcma, moléculas de unión de antígeno específicas que vinculan bcma y cd3, y sus usos relacionados.
ECSP19026178A (es) Anticuerpos anti-pd-1 y sus usos
CY1124118T1 (el) Αντισωματα προσδεσης θυμικης στρωματικης λεμφοποιητινης (tslp) και μεθοδοι χρησης των αντισωματων
CY1119069T1 (el) Σκευασματα αντισωματων υψηλης συγκεντρωσης δια παραπομπη προς συναφεις εφαρμογες
CL2020000192A1 (es) Anticuerpos anti-cd8 y usos de estos.
AR109771A1 (es) Moléculas biespecíficas de unión a antígeno activadoras de células t
CL2019001646A1 (es) Anticuerpos anti-ox40 y sus usos.
CY1123450T1 (el) Μεθοδος καθαρισμου συζευγματων βασει il-15/il-15ra
CY1119849T1 (el) Προ-συντηξης rsv f αντιγονα
BR112018002451A2 (pt) estruturas de ligação com antígeno para moléculas alvo
AR103488A1 (es) Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123
PE20210107A1 (es) Anticuerpos anti-cd3 y metodos de uso
CL2018002898A1 (es) Nuevos anticuerpos anti-sirpa y sus aplicaciones terapéuticas.
CO2017011238A2 (es) Anticuerpos anti-c1s humanizados
BR112017006598A2 (pt) anticorpo de repetições antidipeptídeo derivado de ser humano (dprs)
CL2018003072A1 (es) Anticuerpos anti-basigin humanizados y uso de los mismos.